At a glance
- Originator Fujisawa
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 10 Mar 1999 Discontinued-Preclinical for Neurological disorders (Prevention) in Japan (Unknown route)
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 26 Nov 1997 No-Development-Reported for Neurological disorders (Prevention) in Japan (Unknown route)